Steven F. Bellon
CIK: 0001831749
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Foghorn Therapeutics Inc.
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Jan 30, 2026FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
300K shares at avg. $5.71- - Jan 22, 2025FHTX
Foghorn Therapeutics Inc.
Award(A)DirectStock Option (right to buy)
140K shares at avg. $4.37- - Sep 9, 2024FHTX
Foghorn Therapeutics Inc.
Sale(S)Direct20K shares at avg. $9.50$190K
1-3 of 3 transactions
About Bellon Steven F.
Bellon Steven F. (SEC CIK 0001831749) files insider reports with the SEC as Chief Scientific Officer of Foghorn Therapeutics Inc. (FHTX).
Signal8 holds 3 ownership filings by Bellon Steven F., all Form 4s, filed between Sep 11, 2024 and Feb 2, 2026. Those filings report 3 transactions, from Sep 9, 2024 to Jan 30, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Bellon Steven F.'s filings is in WATERTOWN, MA.
Recent filings by Bellon Steven F.
Other insiders filing for Foghorn Therapeutics Inc. (FHTX)
- BVF PARTNERS L P/IL, 10% Owner
- Lynch Thomas J. Jr., Director
- Duty Stuart, Director
- Biller Scott, Director
- Gallagher Neil, Director
- Mendelsohn Michael, Director